Louis Dubeau
Affiliations: | Biology | University of Southern California, Los Angeles, CA, United States |
Area:
General Biophysics, Molecular Biology, Neuroscience BiologyGoogle:
"Louis Dubeau"Mean distance: 13358.2
Children
Sign in to add trainee| Rajas Chodankar | grad student | 2004 | USC |
| Sepideh Karimi | grad student | 2004 | USC |
| Bongha Shin | grad student | 2004 | USC |
| Jiamei Yu | grad student | 2004 | USC |
| Youngjin Cho | grad student | 2006 | USC |
| Hao Hong | grad student | 2008 | USC |
| Vanessa Yu | grad student | 2009 | USC |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Haran S, Chindera K, Sabry M, et al. (2024) Natural Killer Cell Dysfunction in Premenopausal Mutation Carriers: A Potential Mechanism for Ovarian Carcinogenesis. Cancers. 16 |
| Yuan B, Yang J, Dubeau L, et al. (2021) A Phosphotyrosine Switch in Estrogen Receptor β Is Required for Mouse Ovarian Function. Frontiers in Cell and Developmental Biology. 9: 649087 |
| Dong S, Khedro T, Ward P, et al. (2020) First reported case of BRAF V600E mutation in T-cell prolymphocytic leukaemia. British Journal of Haematology |
| Widschwendter M, Dubeau L. (2020) Non-Surgical Cancer Risk Reduction in Mutation Carriers: Disabling the Remote Control. Cancers. 12 |
| Samanta S, Tamura S, Dubeau L, et al. (2020) Clinicopathological significance of endoplasmic reticulum stress proteins in ovarian carcinoma. Scientific Reports. 10: 2160 |
| Markland FS, Swenson S, Minea R, et al. (2019) Abstract C032: A novel integrin-targeted therapeutic agent for ovarian cancer Molecular Cancer Therapeutics |
| Austria T, Marion C, Yu V, et al. (2018) Mechanism of cytokinesis failure in ovarian cystadenomas with defective brca1 and p53 pathways. International Journal of Cancer |
| Barzi A, Campan M, Petterson J, et al. (2018) Assessment of microsatellite instability (MSI) in cell free DNA (cfDNA) of colorectal cancers (CRC) patients (pts). Journal of Clinical Oncology. 36: 672-672 |
| Bacher J, Halberg R, Ward P, et al. (2018) Development of a pan-cancer biomarker panel for improved detection of MSI across all cancer types Annals of Oncology. 29: viii27-viii28 |
| Samanta S, Tamura S, Dubeau L, et al. (2017) Expression of protein disulfide isomerase family members correlates with tumor progression and patient survival in ovarian cancer. Oncotarget. 8: 103543-103556 |